Stericure Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 1181.09%
- Profit Growth -475.60%
- Ebitda -600.24%
- Net Worth -35.39%
- Total Assets -31.78%
About Stericure Pharmaceuticals
Stericure Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 November 2016 (Eight years and three months 11 days old ). Its registered office is in Pondicherry, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sekhar Marella and Swathi serve as directors at the Company.
Company Details
- Location
Pondicherry, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24309PY2016PTC008110
- Company No.
008110
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 2016
- Date of AGM
28 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Pondicherry
Industry
Who are the key members and board of directors at Stericure Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sekhar Marella  | Director | 15-Nov-2016 | Current |
| Swathi | Director | 15-Nov-2016 | Current |
Financial Performance of Stericure Pharmaceuticals.
Stericure Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 1181.09% increase. The company also saw a substantial fall in profitability, with a 475.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 35.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stericure Pharmaceuticals?
In 2021, Stericure Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ramachandra Sankara Netra Chikitsalaya L LpSwathi is a mutual person
- United Heritage Sports & Arts Federation
Swathi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Stericure Pharmaceuticals?
Unlock and access historical data on people associated with Stericure Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stericure Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stericure Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.